Use of diazolidinyl urea for anti-clumping of biological samples
View Patent ↗The present invention provides methods for preventing clumping of cells in microfluidic devices by addition of diazolidinyl urea (DU). DU can be added to samples at the time of collection or can be added to samples post-collection. DU can also be pre-added to sample collection devices.
1. A method of inhibiting cellular aggregation in a biologically active sample comprising mixing an effective amount of diazolidinyl urea with a sample of viable cells, wherein the effective amount of diazolidinyl urea is in a concentration of about 0.01% to about 3% upon mixing with the sample of viable cells.
2. The method of claim 1 , further comprising mixing an effective amount of diazolidinyl urea in combination with a non-chelating agent based anti-coagulating agent with the sample.
3. The method of claim 1 , further comprising mixing an effective amount of diazolidinyl urea in combination with acid citrate dextrose with the biological sample.
4. The method of claim 1 , wherein the diazolidinyl urea is mixed with the sample before or during a biological sample processing or testing.
5. The method of claim 1 , wherein the diazolidinyl urea is in a solid or liquid form in a container and wherein the biological sample is added to the container.
6. The method of claim 1 , wherein the biological sample is selected from the group consisting of whole blood, blood serum, plasma and bone marrow.
7. The method of claim 1 , wherein upon mixing with the effective amount of diazolidinyl urea the biological sample is suitable for use in a microchannel for cell capturing.
8. The method of claim 1 , wherein the effective amount of diazolidinyl urea in the biological sample provides for improved cell capture in a microchannel as compared to that in the absence of diazolidinyl urea in the biological sample.
9. A method of inhibiting cellular aggregation in a biological sample comprising mixing an effective amount of diazolidinyl urea with the sample, wherein cellular aggregation is reduced in the presence of diazolidinyl urea compared to the absence of diazolidinyl urea in the sample, wherein the effective amount of diazolidinyl urea is about 0.01% to about 3% upon mixing with the biological sample, and wherein upon mixing with the effective amount of diazolidinyl urea the biological sample is suitable for use in a microchannel for cell capturing.
10. The method of claim 1 , wherein the effective amount of diazolidinyl urea is about 0.1% to about 2.5% upon mixing with the biological sample.
11. The method of claim 1 , wherein the effective amount of diazolidinyl urea is about 0.2% to about 2% upon mixing with the biological sample.